prednisone has been researched along with Hyperaldosteronism in 11 studies
Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
Hyperaldosteronism: A condition caused by the overproduction of ALDOSTERONE. It is characterized by sodium retention and potassium excretion with resultant HYPERTENSION and HYPOKALEMIA.
| Excerpt | Relevance | Reference |
|---|---|---|
| " This trial evaluated the efficacy and safety of AA in combination with prednisone to reduce the symptoms of secondary hyperaldosteronism that can occur with AA monotherapy." | 5.14 | Phase II multicenter study of abiraterone acetate plus prednisone therapy in patients with docetaxel-treated castration-resistant prostate cancer. ( Anand, A; Bubley, GJ; Danila, DC; de Bono, JS; Denmeade, SR; Fleisher, M; Haqq, C; Kheoh, T; Koscuiszka, M; Larson, SM; Molina, A; Morris, MJ; Ryan, CJ; Scher, HI; Schwartz, LH; Smith, MR; Taplin, ME, 2010) |
| " A 64-year-old woman with diffuse histiocytic lymphoma developed persistent hypokalemia following a course of Cytoxan (cyclophosphamide), Adriamycin (doxorubicin), vincristine, and prednisone (CHOP)-Bleo." | 3.67 | Potassium-wasting nephropathy secondary to chemotherapy simulating Bartter's syndrome. ( Floyd, M; Lieber, IH; McGuffin, WL; Stoneburner, SD, 1984) |
| "Dexamethasone-suppressible hyperaldosteronism should be considered in hypertensive infants who have normal genitalia and low PRA." | 1.27 | Low-renin hypertension in young infants. ( Field, ML; Roy, S; Stapleton, FB, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (63.64) | 18.7374 |
| 1990's | 2 (18.18) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Battistel, M | 1 |
| Ceolotto, G | 1 |
| Barbiero, G | 1 |
| Rossitto, G | 1 |
| Rossi, GP | 1 |
| Danila, DC | 1 |
| Morris, MJ | 1 |
| de Bono, JS | 1 |
| Ryan, CJ | 1 |
| Denmeade, SR | 1 |
| Smith, MR | 1 |
| Taplin, ME | 1 |
| Bubley, GJ | 1 |
| Kheoh, T | 1 |
| Haqq, C | 1 |
| Molina, A | 1 |
| Anand, A | 1 |
| Koscuiszka, M | 1 |
| Larson, SM | 1 |
| Schwartz, LH | 1 |
| Fleisher, M | 1 |
| Scher, HI | 1 |
| BEAULIEU, EE | 2 |
| FUNEL, P | 2 |
| LEMONNIER, F | 2 |
| VESIN, P | 2 |
| STEINBECK, AW | 1 |
| Lieber, IH | 1 |
| Stoneburner, SD | 1 |
| Floyd, M | 1 |
| McGuffin, WL | 1 |
| Ganguly, A | 1 |
| Grim, CE | 1 |
| Weinberger, MH | 1 |
| Cugini, P | 1 |
| Battisti, P | 1 |
| Di Palma, L | 1 |
| Cavallini, M | 1 |
| Pozzilli, P | 1 |
| Scibilia, G | 1 |
| Letizia, C | 1 |
| Cassisi, A | 1 |
| Cioli, AR | 1 |
| Marino, B | 1 |
| Norrdin, RW | 1 |
| Histand, MB | 1 |
| Sheahan, HJ | 1 |
| Carpenter, TR | 1 |
| Field, ML | 1 |
| Roy, S | 1 |
| Stapleton, FB | 1 |
| Salti, IS | 1 |
| Stiefel, M | 1 |
| Ruse, JL | 1 |
| Laidlaw, JC | 1 |
| Miniconi, P | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Phase I/II Study of Alisertib in Combination With Abiraterone and Prednisone for Patients With Castration-Resistant Prostate Cancer After Progression on Abiraterone[NCT01848067] | Phase 1/Phase 2 | 9 participants (Actual) | Interventional | 2013-08-14 | Completed | ||
| Phase II Randomized Study of Abiraterone Acetate Plus ADT Versus APALUTAMIDE Versus Abiraterone and APALUTAMIDE in Patients With Advanced Prostate Cancer With Non-castrate Testosterone Levels[NCT02867020] | Phase 2 | 128 participants (Actual) | Interventional | 2017-10-11 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Compared between the two patient subsets using the nonparametric Mann-Whitney test. A comparison of CTC counts between baseline and at progression for those who have progressed will be carried out using either a paired t test or the nonparameteric Wilcoxon matched pairs test. (NCT01848067)
Timeframe: Baseline up to 3 months
| Intervention | Participants (Count of Participants) |
|---|---|
| Treatment (Alisertib, Abiraterone Acetate, Prednisone) | 3 |
Summarized with descriptive statistics. (NCT01848067)
Timeframe: Up to 21 days
| Intervention | Participants (Count of Participants) |
|---|---|
| Treatment (Alisertib, Abiraterone Acetate, Prednisone) | 2 |
1 review available for prednisone and Hyperaldosteronism
| Article | Year |
|---|---|
THE ADRENAL CORTEX AND REPRODUCTIVE FUNCTIONS.
Topics: Addison Disease; Adrenal Cortex; Adrenal Cortex Hormones; Adrenal Glands; Adrenocorticotropic Hormon | 1963 |
1 trial available for prednisone and Hyperaldosteronism
| Article | Year |
|---|---|
Phase II multicenter study of abiraterone acetate plus prednisone therapy in patients with docetaxel-treated castration-resistant prostate cancer.
Topics: Adult; Aged; Aged, 80 and over; Androstenes; Androstenols; Antineoplastic Combined Chemotherapy Prot | 2010 |
Phase II multicenter study of abiraterone acetate plus prednisone therapy in patients with docetaxel-treated castration-resistant prostate cancer.
Topics: Adult; Aged; Aged, 80 and over; Androstenes; Androstenols; Antineoplastic Combined Chemotherapy Prot | 2010 |
Phase II multicenter study of abiraterone acetate plus prednisone therapy in patients with docetaxel-treated castration-resistant prostate cancer.
Topics: Adult; Aged; Aged, 80 and over; Androstenes; Androstenols; Antineoplastic Combined Chemotherapy Prot | 2010 |
Phase II multicenter study of abiraterone acetate plus prednisone therapy in patients with docetaxel-treated castration-resistant prostate cancer.
Topics: Adult; Aged; Aged, 80 and over; Androstenes; Androstenols; Antineoplastic Combined Chemotherapy Prot | 2010 |
9 other studies available for prednisone and Hyperaldosteronism
| Article | Year |
|---|---|
Adrenal venous sampling in dye-allergic primary aldosteronism patients: prevalence, pitfalls and a possible solution.
Topics: Adrenal Glands; Adult; Aged; Carbon Dioxide; Chlorpheniramine; Contrast Media; Drug Hypersensitivity | 2018 |
[Reduction of hyperaldosteronism during ascitic cirrhosis under the effect of delta-cortisone].
Topics: Aldosterone; Ascites; Cortisone; Humans; Hyperaldosteronism; Liver Cirrhosis; Prednisone | 1956 |
[Reduction of hyperaldosteronism during ascitic cirrhosis under the effect of delta-cortisone].
Topics: Aldosterone; Ascites; Cortisone; Humans; Hyperaldosteronism; Liver Cirrhosis; Prednisone | 1956 |
[Reduction of hyperaldosteronism during ascitic cirrhosis under the effect of delta-cortisone].
Topics: Aldosterone; Ascites; Cortisone; Humans; Hyperaldosteronism; Liver Cirrhosis; Prednisone | 1956 |
[Reduction of hyperaldosteronism during ascitic cirrhosis under the effect of delta-cortisone].
Topics: Aldosterone; Ascites; Cortisone; Humans; Hyperaldosteronism; Liver Cirrhosis; Prednisone | 1956 |
Potassium-wasting nephropathy secondary to chemotherapy simulating Bartter's syndrome.
Topics: Aldosterone; Antineoplastic Combined Chemotherapy Protocols; Bartter Syndrome; Bleomycin; Cyclophosp | 1984 |
Anomalous postural aldosterone response in glucocorticoid-suppressible hyperaldosteronism.
Topics: Adrenocorticotropic Hormone; Aldosterone; Depression, Chemical; Dexamethasone; Glucocorticoids; Huma | 1981 |
Secondary aldosteronism documented by plasma renin and aldosterone circadian rhythm in subjects with kidney or heart transplantation.
Topics: Adult; Aldosterone; Circadian Rhythm; Cyclosporine; Female; Heart Transplantation; Humans; Hydrocort | 1992 |
Effects of corticosteroids on mechanical strength of intervertebral joints and vertebrae in dogs.
Topics: Animals; Biomechanical Phenomena; Calcium; Dogs; Hyperaldosteronism; Hypothyroidism; Joints; Prednis | 1990 |
Low-renin hypertension in young infants.
Topics: Dexamethasone; Female; Humans; Hyperaldosteronism; Hypertension; Infant; Male; Prednisone; Renin | 1985 |
Non-tumorous "primary" aldosteronism. I. Type relieved by glucocorticoid (glucocorticoid-remediable aldosteronism).
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adolescent; Adrenalectomy; Adult; Aldosterone; Androgens | 1969 |
[Secondary hyperaldosteronism of ascitogenic cirrhosis. Therapeutic results].
Topics: Humans; Hyperaldosteronism; Liver Cirrhosis; Prednisone; Spironolactone | 1963 |